It has also been suggested that USP14, a deubiquitination ligase, is involved in regulating S100A11 deubiquitination and inhibiting the degradation stability of S100A11, suggesting that S100A11 could be a potential diagnostic biomarker and therapeutic target for CRC. Here, USP14 is linked to colorectal carcinoma.